APTBIO
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.
APTBIO
Social Links:
Industry:
Biotechnology
Founded:
2004-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.aptbiotech.com
Total Employee:
51+
Status:
Active
Total Funding:
28.29 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Content Delivery Network SSL By Default Mobile Non Scaleable Content Nginx Microsoft Azure DNS Ubuntu
Similar Organizations
GemPharmatech
GemPharmatech is a biotechnology firm.
KBP Biosciences
A multinational clinical stage biotechnology company.
Lion TCR
Lion TCR is a clinical-stage biotechnology company.
OliX Pharmaceuticals
OliX is a clinical stage biotechnology company.
Panacea Biotec
Panacea Biotec is an Innovation driven Biotechnology company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
Sun Rock Capital
Sun Rock Capital investment in Series C - APTBIO
GF Xinde Investment Management
GF Xinde Investment Management investment in Series C - APTBIO
Legend Capital
Legend Capital investment in Series B - APTBIO
Funway Capital
Funway Capital investment in Series A - APTBIO
Wuxi New District Investment Group
Wuxi New District Investment Group investment in Series A - APTBIO
Lucion
Lucion investment in Series A - APTBIO
Official Site Inspections
http://www.aptbiotech.com Semrush global rank: 1.87 M Semrush visits lastest month: 11.7 K
- Host name: 222.71.60.50
- IP address: 222.71.60.50
- Location: Shanghai China
- Latitude: 31.0449
- Longitude: 121.4012
- Timezone: Asia/Shanghai
More informations about "APTBIO"
中科新生命 - aptbiotech.com
愿景——成为质谱多组学和数据驱动型生命科学技术服务领导者. 以技术创新、产品创新、服务创新、理念创新作为核心竞争力，将中科新生命缔造成为生命科学领域具有全球影响力的实力品 …See details»
APTBIO - Crunchbase Company Profile & Funding
APTBIO is a proteomic technology firm. APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the …See details»
中科新生命_质谱多组学平台_创新生命科学服务
上海中科新生命生物科技有限公司（aptbio）布局科技服务、生物医药及消费医疗cro服务两大业务板块，致力于成为质谱多组学驱动的生命科学技术服务领导者。See details»
关于我们 - aptbiotech.com
靳文海 生物医药事业部总经理 中国科学院大连化学物理研究所&中国科学院上海生化细胞所分析化学博士，约翰霍普金斯 ...See details»
APTBIO - Products, Competitors, Financials, Employees, …
Headquarters Location. No.58, Yuanmei Rd, Minhang District 15-18F, Building 1. Shanghai, Shanghai, China +86 021-54975031See details»
Applied Protein Technology - PitchBook
Apr 22, 2020 Information on valuation, funding, cap tables, investors, and executives for Applied Protein Technology. Use the PitchBook Platform to explore the full profile.See details»
APTBIO’s Competitors, Revenue, Number of Employees, Funding
APTBIO’s Profile, Revenue and Employees. APTBIO is a pharmaceutical company that researches and develops proteomics, metabolomics, and bioinformatics diagnostic drugs for …See details»
APT BIOTECH PRIVATE LIMITED - Zauba Corp
Jul 26, 2023 Organization * Designation * Username * E-mail address * A valid e-mail address. All e-mails from the system will be sent to this address. ... U73100DL2009PTC189597 and its …See details»
Advanced Proteome Therapeutics - Crunchbase Company Profile …
Advanced Proteome Therapeutics is focused on the development of novel therapeutics for the treatment of cancerous tumors. View contacts for Advanced Proteome Therapeutics to access …See details»
中科新生命：我们的十年 - 企业动态 - 丁香通
Dec 9, 2014 中科新生命：我们的十年，APT，你有多了解？APT，即Shanghai Applied Protein Technology，中文名称为上海中科新生命生物科技有限公司。APT从2004年成立，2005年2月 …See details»
Led by Legend Capital, Multi-omics-leading Enterprise APTBIO …
Aug 19, 2022 Shanghai Applied Protein Technology Co., Ltd. (APTBIO), a leading enterprise focused on mass spectrometry-based multi-omics applied to precision medicine, recently …See details»
Omics Services Provider Aptbiotech Nets Hundreds of Millions of …
Aug 17, 2022 Aptbiotech (Chinese: 中科新生命), focused on mass spectrometry-based multi-omics applied to precision medicine, completed a Series B round of financing worth hundreds …See details»
加入APTBIO寻找新的自己 | 上海中科新生命 诚聘英才 - 企业动态
Mar 16, 2020 [email protected]; [email protected]. 招聘热线：021-54972466 . 无接触远程面试 助力找到好工作 . APTBIO欢迎你的加入！ ...See details»
Chinese Proteomic Technology Firm APTBIO Raises $28M In New …
Apr 23, 2020 APTBIO, a Shanghai-based proteomic technology firm, recently announced that it has completed a RMB200 million (US$28.29 million) series A round of financing, led by Luxin …See details»
加入APTBIO寻找新的自己 | 上海中科新生命 诚聘英才
Mar 16, 2020 [email protected]; [email protected]. 招聘热线：021-54972466. 无接触远程面试 助力找到好工作 . APTBIO欢迎你的加入！ ...See details»
APTBIO Stock Price, Funding, Valuation, Revenue & Financial …
Apr 8, 2024 Funding, Valuation & Revenue. 4 Fundings. APTBIO has raised $28.23M over 4 rounds.. APTBIO's latest funding round was a Series C for on April 8, 2024.See details»
登 录 - APT云盘 - storage.aptbiotech.com:8000
登录APT云盘，获取中科新生命提供的专业生物信息学分析和质谱多组学技术服务。See details»
BiomX acquires fellow bacteria-killing virus company APT - Fierce …
Mar 6, 2024 The drug picked up an FDA orphan drug tag at the start of this year, and results from the phase 2b study are expected in the third quarter of 2025. A phase 2a trial showed …See details»
Led by Legend Capital, Multi-omics-leading Enterprise APTBIO …
Aug 19, 2022 Led by Legend Capital, Multi-omics-leading Enterprise APTBIO Closes Series B with Hundreds of Millions of CNY : HONG KONG, Aug 19, 2022 - (ACN Newswire) - Shanghai …See details»
Cloudreve
You need to enable JavaScript to run this app. Cloudreve. You need to enable JavaScript to run this app. Loading...See details»